全文获取类型
收费全文 | 17425篇 |
免费 | 913篇 |
国内免费 | 52篇 |
专业分类
耳鼻咽喉 | 255篇 |
儿科学 | 464篇 |
妇产科学 | 333篇 |
基础医学 | 2735篇 |
口腔科学 | 429篇 |
临床医学 | 1447篇 |
内科学 | 2995篇 |
皮肤病学 | 378篇 |
神经病学 | 1758篇 |
特种医学 | 944篇 |
外国民族医学 | 5篇 |
外科学 | 2668篇 |
综合类 | 55篇 |
一般理论 | 7篇 |
预防医学 | 664篇 |
眼科学 | 621篇 |
药学 | 1186篇 |
中国医学 | 34篇 |
肿瘤学 | 1412篇 |
出版年
2023年 | 102篇 |
2022年 | 118篇 |
2021年 | 261篇 |
2020年 | 197篇 |
2019年 | 266篇 |
2018年 | 422篇 |
2017年 | 323篇 |
2016年 | 449篇 |
2015年 | 453篇 |
2014年 | 545篇 |
2013年 | 682篇 |
2012年 | 1106篇 |
2011年 | 1058篇 |
2010年 | 603篇 |
2009年 | 509篇 |
2008年 | 937篇 |
2007年 | 963篇 |
2006年 | 920篇 |
2005年 | 922篇 |
2004年 | 882篇 |
2003年 | 778篇 |
2002年 | 760篇 |
2001年 | 434篇 |
2000年 | 448篇 |
1999年 | 378篇 |
1998年 | 127篇 |
1997年 | 80篇 |
1996年 | 97篇 |
1995年 | 66篇 |
1994年 | 75篇 |
1992年 | 173篇 |
1991年 | 162篇 |
1990年 | 173篇 |
1989年 | 154篇 |
1988年 | 153篇 |
1987年 | 156篇 |
1986年 | 158篇 |
1985年 | 158篇 |
1984年 | 109篇 |
1983年 | 119篇 |
1982年 | 73篇 |
1979年 | 147篇 |
1978年 | 83篇 |
1977年 | 86篇 |
1974年 | 73篇 |
1973年 | 84篇 |
1972年 | 76篇 |
1971年 | 65篇 |
1970年 | 73篇 |
1968年 | 73篇 |
排序方式: 共有10000条查询结果,搜索用时 421 毫秒
1.
2.
3.
Anders Elm Pedersen Esben Gjerløff Wedebye Schmidt Jesper Freddie Sørensen Carsten Faber Boye Schnack Nielsen Kim Holmstrøm Silje Haukali Omland Peter Tougaard Søren Skov Bo Bang 《APMIS : acta pathologica, microbiologica, et immunologica Scandinavica》2015,123(7):547-555
TL1A is a TNF‐like cytokine which has been shown to co‐stimulate TH1 and TH17 responses during chronic inflammation. The expression of this novel cytokine has been investigated in inflammatory disorders like rheumatoid arthritis and inflammatory bowel disease, but little is known about expression and induction in psoriasis. Indeed, the pathogenesis in psoriasis is still not fully understood and it is speculated that cytokines other than TNF‐α are important in subsets of patients. Also, for patients with severe disease that are treated with systemic anti‐TNF‐α blockade, novel candidates to be used as disease and response biomarkers are of high interest. Here, we demonstrate TL1A expression in biopsies from psoriatic lesions. Also, we investigated spontaneous and induced TL1A secretion from PBMCs and blood levels from a cohort of psoriasis patients. Here, increased spontaneous secretion from PBMCs was observed as compared to healthy controls and a small subset of patients had highly elevated TL1A in the blood. Interestingly, activation of PBMCs with various cytokines showed a decreased sensitivity for TL1A activation in psoriasis patients compared to healthy controls.TL1A levels in blood and biopsies could not be correlated with disease activity with this patient cohort. Thus, additional large‐scale studies are warranted to investigate TL1A as a biomarker. 相似文献
4.
5.
Dominique Trudel Luminita-Mihaela Avarvarei Michèle Orain Stéphane Turcotte Marie Plante Jean Grégoire Reinhild Kappelhoff David P. Labbé Dimcho Bachvarov Bernard Têtu Christopher M. Overall Isabelle Bairati 《Pathology, research and practice》2019,215(6):152369
Ovarian carcinoma is one of the most lethal malignancies, but only very few prognostic biomarkers are known. The degradome, comprising proteases, protease non-proteolytic homologues and inhibitors, have been involved in the prognosis of many cancer types, including ovarian carcinoma. The prognostic significance of the whole degradome family has not been specifically studied in high-grade serous ovarian cancer. A targeted DNA microarray known as the CLIP-CHIP microarray was used to identify potential prognostic factors in ten high-grade serous ovarian cancer women who had early recurrence (<1.6 years) or late/no recurrence after first line surgery and chemotherapy. In women with early recurrence, we identified seven upregulated genes (TMPRSS4, MASP1/3, SPC18, PSMB1, IGFBP2, CFI – encoding Complement Factor I – and MMP9) and one down-regulated gene (ADAM-10). Using immunohistochemistry, we evaluated the prognostic effect of these 8 candidate genes in an independent cohort of 112 high-grade serous ovarian cancer women. Outcomes were progression, defined according to CA-125 criteria, and death. Multivariate Cox proportional hazard regression models were done to estimate the associations between each protein and each outcome. High ADAM-10 expression (intensity of 2–3) was associated with a lower risk of progression (adjusted hazard ratio (HR): 0.51; 95% confidence interval (CI): 0.29-0.87). High complement factor I expression (intensity 2–3) was associated with a higher risk of progression (adjusted HR: 2.30, 95% CI: 1.17–4.53) and death (adjusted HR: 3.42; 95% CI: 1.72–6.79). Overall, we identified the prognostic value of two proteases, ADAM-10 and complement factor I, for high-grade serous ovarian cancer which could have clinical significance. 相似文献
6.
7.
8.
9.
10.
Marieke C Wichers Gunter Kenis Carsten Leue Ger Koek Geert Robaeys Michael Maes 《Neuropsychopharmacology》2006,60(1):77-79
BACKGROUND: Major depression has been associated cross-sectionally with increased cell-mediated immune activation but causality has been difficult to establish. This study prospectively investigated the hypothesis that baseline level of immune activation predicts the development of depression during interferon-alpha (IFN-alpha) treatment. METHODS: Sixteen hepatitis C patients without psychiatric disorder underwent IFN-alpha treatment. Proinflammatory and anti-inflammatory cytokines were determined before starting treatment. Presence of a major depressive disorder (MDD) was assessed at baseline and several times during treatment. RESULTS: Baseline soluble interleukin-2 receptor (sIL-2r), interleukin-6 (IL-6), and interleukin-10 (IL-10) concentrations were significantly increased in the five subjects that developed MDD during treatment compared with those that did not, with standardized effect sizes of 1.08, 1.16, and 1.25, respectively, controlling for marijuana use, cigarette smoking, and baseline level of depressive symptoms. CONCLUSIONS: Results suggest that increased immune activation, rather than an epiphenomenon, is a causal risk factor for the development of MDD. 相似文献